Begin typing your search above and press return to search.

New prostate cancer diagnosis facility

By Staff Reporter
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo

GUWAHATI, Sept 2 - In its bid to ensure better diagnosis of prostate cancer in the North East, Nucleomed (Nuclear Medicine and Molecular Imaging Centre) here has announced the commissioning of Gallium 68 Generator (positron emitters).

A first of its kind facility in NE, the technology would also help in a more accurate prognosis for nuro endocrine tumour, multiple myoloma, insulinoma, etc.

�Though many of the diseases are very rare, the Prostate Specific Membrane Antigen (Ga 68 PSMA) will immensely help the prostate cancer patients of Assam and other states of the region. The technology has very good sensitivity for diagnosis, staging, restaging and prognostication of the diseases, Dr Kandarpa Saikia, managing trustee of Nucleomed said.

The positive predictive value with PSMA is as high as 98 per cent. Moreover, the scan can detect disease progression and castration resistance in hundred per cent cases.

Dr Saikia claimed that the oncologists and urologists of Assam have appreciated the facility. The Urologists Association of Assam opine that patients from this region need not go outside Assam for many tests.

More in Entertainment
Next Story
Similar Posts
New prostate cancer diagnosis facility

GUWAHATI, Sept 2 - In its bid to ensure better diagnosis of prostate cancer in the North East, Nucleomed (Nuclear Medicine and Molecular Imaging Centre) here has announced the commissioning of Gallium 68 Generator (positron emitters).

A first of its kind facility in NE, the technology would also help in a more accurate prognosis for nuro endocrine tumour, multiple myoloma, insulinoma, etc.

�Though many of the diseases are very rare, the Prostate Specific Membrane Antigen (Ga 68 PSMA) will immensely help the prostate cancer patients of Assam and other states of the region. The technology has very good sensitivity for diagnosis, staging, restaging and prognostication of the diseases, Dr Kandarpa Saikia, managing trustee of Nucleomed said.

The positive predictive value with PSMA is as high as 98 per cent. Moreover, the scan can detect disease progression and castration resistance in hundred per cent cases.

Dr Saikia claimed that the oncologists and urologists of Assam have appreciated the facility. The Urologists Association of Assam opine that patients from this region need not go outside Assam for many tests.

More in Entertainment
Similar Posts